Connecticut Oncology Group
Connecticut Oncology Group, PC is a physician-owned private oncology and hematology practice operating two Connecticut locations, delivering chemotherapy, radiation, hormonal, and targeted therapy to cancer patients while running a Medicare-focused chronic care management program.
- Company typePrivate
- Founded-
- HeadquartersMiddletown, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Connecticut Oncology Group does
Connecticut Oncology Group, PC is a physician-owned, private medical oncology and hematology practice operating two clinical sites in Connecticut: a headquarters at 536 Saybrook Road in Middletown, which includes a dedicated infusion center, and a secondary office on the 2nd floor of the Middlesex Health Cancer Center at 250 Flat Rock Place in Westbrook. The practice employs approximately 30 staff, including four board-certified hematology/oncology physicians (Drs. Farrell, Hong, Kandavelou, and Mariano), two physician assistants, four advanced practice registered nurses, registered nurses, medical assistants, billing specialists, patient care coordinators, and administrative personnel. The practice delivers comprehensive cancer treatment across modalities — chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and surgical coordination — covering bladder, breast, colon, lung, skin, and throat cancers as well as hematologic malignancies and blood disorders.
Revenue is generated primarily through fee-for-service medical billing to commercial insurers, Medicare, and Medicare Advantage, supplemented by patient copays collected at the time of visit. The practice has expanded its service surface with "Connected Care," a Chronic Care Management (CCM) program targeting Medicare and Medicare Advantage patients with multiple chronic conditions, delivering 24/7 text-based support and dedicated care coordination. Patient acquisition is driven by physician referrals (with formal fax-based referral workflows), self-referrals, and the practice's website and NavigatingCare patient portal. The practice has partnered with the OneOncology Platform for operational, clinical, and technology resources while retaining independence, and is co-located within the Middlesex Health Cancer Center, providing access to that health system's clinical trials and broader care continuum. HIPAA compliance is maintained through standard patient registration and privacy documentation.
Connecticut Oncology Group firmographics
Firmographics- Name
- Connecticut Oncology Group
- Legal name
- Connecticut Oncology Group, PC
- Website
- https://ctoncgrp.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Connecticut Oncology Group, PC is a physician-owned private oncology and hematology practice operating two Connecticut locations, delivering chemotherapy, radiation, hormonal, and targeted therapy to cancer patients while running a Medicare-focused chronic care management program.
- Ownership category
- akta.pro rank
Connecticut Oncology Group industry classification
Industry- Product category
- Oncology Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621), Other Outpatient Care Centers (62149)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Surgical Oncology (HLAKAFAG)
Keywords
Where Connecticut Oncology Group is headquartered
LocationHeadquarters
- HQ city
- Middletown
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Connecticut Oncology Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Revenue model
- Oncology and Hematology Medical Services: The practice generates revenue through fee-for-service medical care including consultations, chemotherapy administration, radiation therapy, surgery coordination, hormonal therapy, and targeted therapy. Revenue is collected through insurance reimbursements, patient copays, and insurance billing. The Connected Care chronic care management program also generates revenue through Medicare/Medicare Advantage copays.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard oncology care with insurance billing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Connecticut Oncology Group product offering
Product offeringCore offering
Connecticut Oncology Group provides in-person medical oncology and hematology care, delivering chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and surgery coordination for cancers including bladder, breast, colon, lung, skin, throat, and hematologic malignancies. The practice operates an in-house infusion center at its Middletown headquarters and a secondary clinic at Middlesex Health Cancer Center in Westbrook, supplemented by the Connected Care chronic care management program and a NavigatingCare patient portal.
Product overview
Connecticut Oncology Group is a medical oncology practice offering comprehensive cancer treatment services. The practice provides in-person treatment modalities including surgery, chemotherapy, radiation therapy, hormonal therapy, and targeted therapy for various cancer types. In addition to core treatment services, the practice offers a Chronic Care Management program called Connected Care, which provides ongoing support for patients with chronic conditions via text messaging and care coordination. The practice also provides patient access through an online patient portal for managing appointments and medical records.
Differentiator
Problem solved
Functional benefit
Brands
- Connected Care: Chronic Care Management (CCM) program supporting CT Oncology Group patients with chronic conditions such as diabetes, heart disease, high blood pressure, and arthritis. Includes text-based communication with care team, health coaching, and care plan management.
Products and services
- Cancer Treatment Services Comprehensive in-person oncology and hematology care covering chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and surgical coordination for adult cancer patients across multiple tumor types.
- Connected Care Chronic Care Management Ongoing chronic care management for Medicare and Medicare Advantage patients with two or more chronic conditions, providing a comprehensive care plan, monthly check-ins, medication coordination, health coaching, and 24/7 text-based access to a dedicated care manager.
- Patient Portal (NavigatingCare) Online portal that allows Connecticut Oncology Group patients to access medical records, view statements, pay bills, and manage appointments.
Companies that use Connecticut Oncology Group
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Connecticut Oncology Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Connecticut Oncology Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- OneOncology PlatformcoreConnecticut Oncology Group has partnered with OneOncology Platform, a network designed to help independent oncology practices deliver high-quality cancer care. The partnership provides access to shared resources, clinical best practices, and operational support to help optimize patient outcomes. The practice maintains its independence while benefiting from the OneOncology network's collective expertise and technology.
Scale indicators2 records
Recent moves1 record
Expansion highlights5 records
Connecticut Oncology Group competitors and assessment
Company assessmentDirect peers
- Tennessee Oncology: Large independent community oncology practice and a OneOncology platform partner; closely mirrors CT Oncology Group's physician-ownership, fee-for-service, multi-modality treatment model at greater scale.
- New York Cancer & Blood Specialists: Independently owned, multi-site hematology/oncology practice and OneOncology partner operating infusion and chronic care programs in the Northeast — a near-identical operating model to CT Oncology Group.
- Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the U.S., offering medical oncology, hematology, infusion, and clinical trials across many sites — same service mix and physician-ownership ethos.
- Texas Oncology: Large independent community oncology practice affiliated with The US Oncology Network; delivers medical oncology, radiation, and infusion services in an outpatient setting, comparable to CT Oncology Group's model.
- Arizona Oncology: US Oncology Network-affiliated community oncology practice providing medical oncology, hematology, and infusion across multiple Arizona locations — comparable scale and outpatient care delivery.
- Virginia Cancer Specialists: Large independent community oncology practice operating infusion centers, clinical trials, and chronic care across Virginia — directly comparable outpatient delivery model.
Broad incumbents
- The US Oncology Network: National network of independent oncology practices sharing infrastructure, technology, and clinical resources — analogous to OneOncology, the platform that supports CT Oncology Group.
- Smilow Cancer Hospital (Yale New Haven Health): Academic/hospital-based cancer program in Connecticut offering medical oncology, radiation, surgery, and clinical trials; competes for the same regional patient pool as CT Oncology Group but at inpatient/academic scale.
- Hartford HealthCare Cancer Institute: Connecticut-based health-system cancer program offering multi-specialty oncology services across the state; competes with CT Oncology Group for community hematology/oncology referrals.
Others
- OneOncology: Strategic platform partner of CT Oncology Group; selected because it is a directly contracted enabler/ecosystem participant rather than a competitor, providing practice management, technology, and clinical best practices.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Connecticut Oncology Group social profiles
Digital presenceConnecticut Oncology Group compliance and trust
Trust signalCompliance1 record
Connecticut Oncology Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Connecticut Oncology Group leadership team
Management profileNumber of profiles
Profiles9 records
Connecticut Oncology Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Connecticut Oncology Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Connecticut Oncology Group
What does Connecticut Oncology Group do?
Connecticut Oncology Group provides in-person medical oncology and hematology care, delivering chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and surgery coordination for cancers including bladder, breast, colon, lung, skin, throat, and hematologic malignancies. The practice operates an in-house infusion center at its Middletown headquarters and a secondary clinic at Middlesex Health Cancer Center in Westbrook, supplemented by the Connected Care chronic care management program and a NavigatingCare patient portal.
Is Connecticut Oncology Group a public or private company?
Connecticut Oncology Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Connecticut Oncology Group founded?
Connecticut Oncology Group was founded in -1. It employs 11 to 50 people.
Where is Connecticut Oncology Group based?
Connecticut Oncology Group is headquartered in Middletown, United States, in the North America region.
How does Connecticut Oncology Group make money?
One revenue line is on record: oncology and Hematology Medical Services.
Who are Connecticut Oncology Group's main competitors?
Direct peers on record are Tennessee Oncology, New York Cancer & Blood Specialists, Florida Cancer Specialists & Research Institute, Texas Oncology, Arizona Oncology and Virginia Cancer Specialists. Broad incumbents are The US Oncology Network, Smilow Cancer Hospital (Yale New Haven Health) and Hartford HealthCare Cancer Institute. OneOncology is listed as an others.
Does Connecticut Oncology Group have an API?
No public API is recorded for Connecticut Oncology Group.
What industry is Connecticut Oncology Group in?
Connecticut Oncology Group's product category is Oncology Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.